Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Modified Ultrafiltration on Vancomycin Levels During Cardiopulmonary Bypass in Cardiac Surgery

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: NONE
- Phase: EARLY_PHASE1
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled to undergo cardiac surgery with cardiopulmonary bypass and modified ultrafiltration~* age greater than 18 years old~* penicillin allergy or in-hospital stay greater than 24 hours~* normal renal function~* normal liver function~* absence of clinical and laboratory signs of infection~Exclusion Criteria:~* vancomycin allergy~* pregnancy~* impaired renal function~* impaired liver function~* morbid obesity~* active infections~* Jehovah's Witness

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 99 Years
- Healthy Volunteers: f

Study Arms:
- Vancomycin concentrations (Type: OTHER): Up to ten blood samples testing for vancomycin concentrations will be collected in subjects administered vancomycin as prophylaxis before cardiac surgery with cardiopulmonary bypass and modified ultrafiltration.

Based on this trial design, predict the completion outcome and termination type (if applicable).